iRhythm Technologies (IRTC) Stock Price, News & Analysis

Company Overview

iRhythm Technologies, Inc. is a medical technology company that develops and commercializes wearable cardiac monitoring devices and associated data analytics services. Founded in 2006 and headquartered in San Francisco, California, the company’s flagship product is the Zio® patch, a discreet, single-use, continuous ECG recorder designed to monitor heart rhythms for up to 14 days. iRhythm’s digital diagnostics platform combines biosensor technology with proprietary algorithms to detect arrhythmias and streamline data interpretation for physicians.

The Zio service is prescribed by cardiologists and other healthcare providers to aid in the diagnosis of atrial fibrillation, bradycardia, tachycardia and other rhythm disorders. After wearing the water-resistant patch, patients mail it back to iRhythm’s central lab, where recorded data are analyzed using the company’s AI-powered architecture. A comprehensive report, including annotated ECG strips and rhythm diagnosis, is delivered directly to the prescribing clinician, helping to guide treatment decisions.

iRhythm primarily serves the United States market through partnerships with hospitals, clinics and diagnostic laboratories, and the company has been expanding its global footprint through strategic collaborations and regulatory approvals in select international markets. Leadership is headed by President and Chief Executive Officer Kevin King, who has overseen product innovation and process enhancements to support scalable growth. iRhythm continues to invest in research and development to extend its diagnostic platform into emerging areas of cardiovascular care and digital health.

Key Stats

• Today's Range: $168.95 to $172.40
• 50-Day Range: $132.29 to $171.47
• 52-Week Range: $55.92 to $172.59
• Volume: 193,610 shs
• Average Volume: 545,079 shs
• Market Capitalization: $5.46 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $163.82
• Consensus Rating: Buy

iRhythm Technologies Stock Analysis - MarketRank™

iRhythm Technologies scored higher than 28% of companies evaluated by MarketBeat, and ranked 847th out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.5 / 5
• Analyst Rating: Buy

Consensus Rating

iRhythm Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 10 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

iRhythm Technologies has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for iRhythm Technologies are expected to grow in the coming year, from ($1.98) to ($1.03) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of iRhythm Technologies is -58.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of iRhythm Technologies is -58.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

iRhythm Technologies has a P/B Ratio of 52.63. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

7.93% of the float of iRhythm Technologies has been sold short.

Short Interest Ratio / Days to Cover

iRhythm Technologies has a short interest ratio ("days to cover") of 5.1.

Change versus previous month

Short interest in iRhythm Technologies has recently increased by 1.20%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

iRhythm Technologies does not currently pay a dividend.

Dividend Growth

iRhythm Technologies does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

7.93% of the float of iRhythm Technologies has been sold short.

Short Interest Ratio / Days to Cover

iRhythm Technologies has a short interest ratio ("days to cover") of 5.1.

Change versus previous month

Short interest in iRhythm Technologies has recently increased by 1.20%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 4.1 / 5
• News Sentiment: 1.35

News Sentiment

iRhythm Technologies has a news sentiment score of 1.35. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.09 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 13 news articles for iRhythm Technologies this week, compared to 7 articles on an average week.

Search Interest

13 people have searched for IRTC on MarketBeat in the last 30 days. This is an increase of 333% compared to the previous 30 days.

MarketBeat Follows

2 people have added iRhythm Technologies to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, iRhythm Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $7,549,869.00 in company stock.

Percentage Held by Insiders

Only 1.10% of the stock of iRhythm Technologies is held by insiders.

IRTC Stock Analysis - Frequently Asked Questions

How have IRTC shares performed this year?

iRhythm Technologies' stock was trading at $90.17 at the beginning of 2025. Since then, IRTC stock has increased by 88.5% and is now trading at $169.98.

How were iRhythm Technologies' earnings last quarter?

iRhythm Technologies (NASDAQ:IRTC) announced its quarterly earnings data on Thursday, July, 31st. The company reported ($0.32) EPS for the quarter, beating analysts' consensus estimates of ($0.53) by $0.21. The firm's revenue for the quarter was up 26.1% compared to the same quarter last year.
Read the conference call transcript.

When did iRhythm Technologies IPO?

iRhythm Technologies (IRTC) raised $76 million in an initial public offering (IPO) on Thursday, October 20th 2016. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

Who are iRhythm Technologies' major shareholders?

iRhythm Technologies' top institutional shareholders include Sands Capital Management LLC (9.07%), Artisan Partners Limited Partnership (8.53%), Geode Capital Management LLC (2.39%) and Blair William & Co. IL (2.32%). Insiders that own company stock include Quentin S Blackford, Mark J Day, Chad Patterson, Minang Turakhia, Daniel G Wilson, Patrick Michael Murphy, Sumi Shrishrimal, Douglas Devine, Brice Bobzien, Abhijit Y Talwalkar, Mervin Smith, Marc Wade Rosenbaum, Marc W Rosenbaum and Merz Cathleen Noel Bairey.
View institutional ownership trends.

How do I buy shares of iRhythm Technologies?

Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of iRhythm Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that iRhythm Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Advanced Micro Devices (AMD), Arista Networks (ANET) and ServiceNow (NOW).

Company Calendar

• Last Earnings: 7/31/2025
• Today: 8/31/2025
• Next Earnings (Estimated): 10/29/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MEDICAL INFO SYS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:IRTC
• CIK: 1388658
• Web: www.irhythmtech.com
• Phone: (415) 632-5700
• Fax: N/A
• Employees: 2,000
• Year Founded: 2006

Price Target and Rating

• Average Price Target for iRhythm Technologies: $163.82
• High Price Target: $200.00
• Low Price Target: $120.00
• Potential Upside/Downside: -3.6%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 12 Analysts

Profitability

• EPS (Trailing Twelve Months): ($2.93)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$113.29 million
• Net Margins: -14.06%
• Pretax Margin: -13.94%
• Return on Equity: -90.03%
• Return on Assets: -8.52%

Debt

• Debt-to-Equity Ratio: 6.25
• Current Ratio: 5.02
• Quick Ratio: 4.88

Sales & Book Value

• Annual Sales: $591.84 million
• Price / Sales: 9.23
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $3.23 per share
• Price / Book: 52.63

Miscellaneous

• Outstanding Shares: 32,130,000
• Free Float: 31,775,000
• Market Cap: $5.46 billion
• Optionable: Optionable
• Beta: 1.41